Skip to main content
Premium Trial:

Request an Annual Quote

Eurobio Scientific to Distribute Vela Diagnostics Products in UK, Europe

NEW YORK – Vela Diagnostics said this week that it has inked an agreement with Eurobio Scientific to distribute Vela's products in the UK and in Europe. 

The deal includes Eurobio Scientific UK and other companies within the Eurobio Scientific Group in Germany, the Benelux countries, and France, Vela said in a statement. 

The Singapore-based company has developed 13 next-generation sequencing-based panels for oncology, microbiology, and virology. It also has a qPCR workflow and 31 PCR-based tests for a variety of diseases, including gastroenteritis, zoonotic diseases, blood-borne viruses, respiratory infections, and sexually transmitted infections. 

The firm's Sentosa workflow includes qPCR, NGS on a sequencing instrument manufactured for Vela by Thermo Fisher Scientific, and reporting functions. With some UK customers, the company has designed its workflow to work with Illumina sequencers, Vela said.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.